Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review). | Int J Oncol | 2021 | 34368858 | PubTator, text mining | PubMed |
| Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma. | Front Oncol | 2021 | 34367948 | PubTator, text mining | PubMed |
| Staphylococcus aureus Decreases SUMOylation Host Response to Promote Intramacrophage Survival. | Int J Mol Sci | 2021 | 34360873 | PubTator, text mining | PubMed |
| SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone. | Cancers (Basel) | 2021 | 34359724 | PubTator, text mining | PubMed |
| Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies. | Cancers (Basel) | 2021 | 34359720 | PubTator, text mining | PubMed |
| Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple Myeloma. | Cancers (Basel) | 2021 | 34359660 | PubTator, text mining | PubMed |
| Wrestling and Wrapping: A Perspective on SUMO Proteins in Schwann Cells. | Biomolecules | 2021 | 34356679 | PubTator, text mining | PubMed |
| Mechanism and function of DNA replication-independent DNA-protein crosslink repair via the SUMO-RNF4 pathway. | EMBO J | 2021 | 34346517 | PubTator, text mining | PubMed |
| SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis. | Int J Biol Sci | 2021 | 34345216 | PubTator, text mining | PubMed |
| Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system. | J Neurovirol | 2021 | 34342851 | PubTator, text mining | PubMed |
| High Migration and Invasion Ability of PGCCs and Their Daughter Cells Associated With the Nuclear Localization of S100A10 Modified by SUMOylation. | Front Cell Dev Biol | 2021 | 34336846 | PubTator, text mining | PubMed |
| SUMO and SUMOylation Pathway at the Forefront of Host Immune Response. | Front Cell Dev Biol | 2021 | 34336833 | PubTator, text mining | PubMed |
| Advances in SUMO-based regulation of homologous recombination. | Curr Opin Genet Dev | 2021 | 34333341 | PubTator, text mining | PubMed |
| SUMOylated non-canonical polycomb PRC1.6 complex as a prerequisite for recruitment of transcription factor RBPJ. | Epigenetics Chromatin | 2021 | 34332624 | PubTator, text mining | PubMed |
| SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells. | Nat Commun | 2021 | 34321470 | PubTator, text mining | PubMed |
| SUMO proteases SENP3 and SENP5 spatiotemporally regulate the kinase activity of Aurora A. | J Cell Sci | 2021 | 34313310 | PubTator, text mining | PubMed |
| Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay. | Acta Biochim Biophys Sin (Shanghai) | 2021 | 34312671 | PubTator, text mining | PubMed |
| Study of the Expression and Function of Calcium-Sensing Receptor in Human Skeletal Muscle. | Int J Mol Sci | 2021 | 34298895 | PubTator, text mining | PubMed |
| Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer. | Cancers (Basel) | 2021 | 34298700 | PubTator, text mining | PubMed |
| RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. | Cancers (Basel) | 2021 | 34298689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=29